IP Verse

Deva Holding competitive analysis

Explore patent oppositions filed by Deva Holding against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 29, 2026

Patent Number	Title	Applicant	Opposition Date
EP4218732	Tablets Comprising Eltrombopag Olamine	NOVARTIS	Dec 16, 2025
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 22, 2025

Discover the latest PTAB cases involving Deva Holding, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Deva Holding with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 29, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
DEVA HOLDING	2	-	-	-
NOVARTIS	6	424	-	21